AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 191 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 3.93 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $81,000 | +50.0% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $54,000 | -25.0% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $72,000 | +46.9% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $49,000 | -34.7% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $75,000 | -26.5% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $102,000 | +45.7% | 1,500 | -0.9% | 0.00% | 0.0% |
| Q4 2018 | $70,000 | -40.2% | 1,513 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $117,000 | -7.9% | 1,513 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $127,000 | +3.3% | 1,513 | +0.9% | 0.00% | 0.0% |
| Q1 2018 | $123,000 | -23.1% | 1,500 | -46.4% | 0.00% | -50.0% |
| Q4 2017 | $160,000 | -14.4% | 2,800 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $187,000 | +29.9% | 2,800 | 0.0% | 0.00% | +100.0% |
| Q2 2017 | $144,000 | +14300.0% | 2,800 | +69900.0% | 0.00% | – |
| Q4 2015 | $1,000 | – | 4 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 354,650 | $18,314,000 | 7.19% |
| Casdin Capital, LLC | 2,165,000 | $111,801,000 | 3.33% |
| Rock Springs Capital Management LP | 2,543,600 | $131,352,000 | 2.87% |
| HealthCor Management, L.P. | 1,532,960 | $79,162,000 | 2.80% |
| Bellevue Group AG | 4,537,092 | $234,295,000 | 2.48% |
| Woodline Partners LP | 824,097 | $42,556,000 | 0.94% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,081,347 | $55,841,000 | 0.83% |
| Integral Health Asset Management, LLC | 43,000 | $2,221,000 | 0.64% |
| ArrowMark Colorado Holdings LLC | 1,119,566 | $57,814,000 | 0.43% |
| Virtus ETF Advisers LLC | 18,328 | $946,000 | 0.40% |